Delivery Order SPE2DB22D3019-SPE2DB25FK4BD
Award Date 8/8/25
Potential Completion Date 8/11/25
Potential Value $17K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $5,910.20 delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Losartan-HCTZ 100-12.5 mg tablets in quantities of 90 units. This firm fixed-price delivery order, which is not set-aside designated, is set to complete on July 23, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting federal medical supply...
- The Defense Logistics Agency awarded a delivery order valued at $1,683.45 to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Losartan-HCTZ 100-12.5 mg tablets in quantities of 90. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded procurement. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of July 29, 2025. This award represents a routine...
- The Defense Logistics Agency awarded a $2,162.93 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Losartan-HCTZ 50-12.5 mg tablets (90-count supply) on August 7, 2025, with a completion date of August 8, 2025. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $19,748.97 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Losartan-HCTZ 100-12.5 mg tablets in a quantity of 90 units. The contract employs firm fixed-price pricing with no set-aside designation and is scheduled for completion by July 28, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Losartan-HCTZ 100-12.5 mg tablets in a quantity of 90 units, with a ceiling value of $2,609.93. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The order is set for ultimate completion on July 22, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Losartan-HCTZ 100-25 mg tablets in quantities of 1,000 units, with a contract ceiling value of $1,095.47. This firm fixed-price delivery order, which is set to be completed by July 23, 2025, represents a single-transaction pharmaceutical procurement from the company's corporate office location in Conshohocken, Pennsylvania. The award was competitively awarded with no...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp valued at $2,400.84 for the supply of Losartan-HCTZ 100-12.5 mg tablets in 90-count packages. This contract, awarded on August 1, 2025, with an ultimate completion date of August 4, 2025, represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award status. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Losartan-HCTZ 50-12.5 mg tablets (90-count) with a ceiling value of $7,068.10. This firm fixed-price, competitive delivery order was executed on July 30, 2025, with an ultimate completion date of July 31, 2025. The contract carries no set-aside designation, indicating open competition among eligible vendors. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will...
- The Defense Logistics Agency awarded a delivery order valued at $1,084.59 to AmerisourceBergen Drug Corp for the supply of Losartan Potassium 25 mg tablets in quantities of 1,000 units. This order, which was competitively awarded without a set-aside designation, represents a firm fixed-price delivery under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The product will be delivered to AmerisourceBergen's Conshohocken, Pennsylvania location, with an...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of 1,000 tablets of Losartan Potassium 50 mg at a ceiling value of $1,120.32. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 5, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The contract utilizes no set-aside designation and is classified as a child contract under a larger vehicle. This...